Rene Sindlev - 01 Aug 2023 Form 4 Insider Report for RENOVARO BIOSCIENCES INC. (RENB)

Role
Director, 10%+ Owner
Signature
/s/ Rene Sindlev
Issuer symbol
RENB
Transactions as of
01 Aug 2023
Net transactions value
+$499,998
Form type
4
Filing time
12 Sep 2023, 06:08:23 UTC
Previous filing
01 Aug 2023
Next filing
15 Feb 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RENB Series A Convertible Preferred Stock Award $499,998 +70,126 $7.13 70,126 01 Aug 2023 Common Stock 701,260 $0.000000 By RS Bio ApS F1, F2
transaction RENB Warrant (Right to Buy) Award $0 +350,630 $0.000000 350,630 01 Aug 2023 Common Stock 350,630 $0.6500 By RS Bio ApS F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Series A Convertible Preferred Stock ("Preferred Stock") is convertible into Common Stock on a one-for-ten basis
F2 The Preferred Stock is perpetual and has no expiration date.
F3 Granted to the Reporting Person as warrant coverage in connection with the Preferred Stock reported above.